Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.8K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.8K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

2.9K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.9K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

6.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

4.6K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.6K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

1.1K
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

US transgender care providers face legal dilemma.

Lancet (London, England)ยท2025
Same author

Robert F Kennedy Jr's promises.

Lancet (London, England)ยท2025
Same author

Trump agenda ignites legal challenges.

Lancet (London, England)ยท2025
Same author

Can the US health-care workforce keep pace with demand?

Lancet (London, England)ยท2024
Same author

FDA panel says preterm birth drug should be withdrawn.

Lancet (London, England)ยท2024
Same author

Harris or Trump? Health in the US election.

Lancet (London, England)ยท2024
Same journal

Temporal changes in cortisol secretion and their association with long-term outcomes in benign adrenal incidentalomas: a retrospective cohort study.

The lancet. Diabetes & endocrinologyยท2026
Same journal

Human versus analogue insulin for children and young adults with type 1 diabetes in low-resource settings (HumAn-1): a multicentre, open-label, randomised controlled trial.

The lancet. Diabetes & endocrinologyยท2026
Same journal

Insulin and health systems in global low-resource settings.

The lancet. Diabetes & endocrinologyยท2026
Same journal

Weight management in China: integrating mental health into routine obesity care.

The lancet. Diabetes & endocrinologyยท2026
Same journal

Innovation is key to transforming future obesity care.

The lancet. Diabetes & endocrinologyยท2026
Same journal

Out of touch medical care.

The lancet. Diabetes & endocrinologyยท2026
See all related articles

Related Experiment Video

Updated: Apr 13, 2026

In vitro Induction of Human Dental Pulp Stem Cells Toward Pancreatic Lineages
07:32

In vitro Induction of Human Dental Pulp Stem Cells Toward Pancreatic Lineages

Published on: September 25, 2021

3.8K

US initiative for prediabetes.

Susan Jaffe

    The Lancet. Diabetes & Endocrinology
    |April 30, 2015
    PubMed
    Summary
    This summary is machine-generated.

    US health officials urge physicians to combat rising diabetes rates by referring at-risk patients to proven diabetes prevention programs. Early intervention through these programs is key to reducing the diabetes burden.

    More Related Videos

    Multidisciplinary Approach to Obesity Management: A Case Report
    05:10

    Multidisciplinary Approach to Obesity Management: A Case Report

    Published on: May 30, 2025

    1.5K
    Lentiviral Mediated Gene Silencing in Human Pseudoislet Prepared in Low Attachment Plates
    11:24

    Lentiviral Mediated Gene Silencing in Human Pseudoislet Prepared in Low Attachment Plates

    Published on: May 14, 2019

    5.9K

    Related Experiment Videos

    Last Updated: Apr 13, 2026

    In vitro Induction of Human Dental Pulp Stem Cells Toward Pancreatic Lineages
    07:32

    In vitro Induction of Human Dental Pulp Stem Cells Toward Pancreatic Lineages

    Published on: September 25, 2021

    3.8K
    Multidisciplinary Approach to Obesity Management: A Case Report
    05:10

    Multidisciplinary Approach to Obesity Management: A Case Report

    Published on: May 30, 2025

    1.5K
    Lentiviral Mediated Gene Silencing in Human Pseudoislet Prepared in Low Attachment Plates
    11:24

    Lentiviral Mediated Gene Silencing in Human Pseudoislet Prepared in Low Attachment Plates

    Published on: May 14, 2019

    5.9K

    Area of Science:

    • Public Health
    • Preventive Medicine
    • Endocrinology

    Background:

    • Diabetes prevalence in the USA is a significant public health concern.
    • Physicians play a crucial role in identifying at-risk individuals for diabetes.
    • Diabetes prevention programs offer evidence-based strategies to mitigate risk.

    Discussion:

    • Health officials are advocating for increased physician involvement in diabetes prevention.
    • Referral to structured prevention programs is a key recommendation.
    • This initiative aims to curb the growing incidence of diabetes.

    Key Insights:

    • Physician-led referrals are essential for successful patient engagement in prevention programs.
    • Early identification and intervention can significantly lower diabetes risk.
    • Public health strategies emphasize proactive patient management.

    Outlook:

    • Wider adoption of this physician-led referral model could reduce long-term diabetes complications.
    • Continued emphasis on preventive care is vital for population health.
    • Future efforts may focus on integrating prevention program enrollment into routine clinical practice.